Free testosterone levels and implications on clinical outcomes in elderly men

Aging Clinical and Experimental Research

Volumn 20, Issue 3, 2008, Pages 201-206

  Yavuz, Burcu Balam ^a   Ozkayar, Nihal ^a   Halil, Meltem ^a   Cankurtaran, Mustafa ^a   Ulger, Zekeriya ^a   Tezcan, Engin ^a   Gurlek, Alper ^a   Ariogul, Servet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aging; Cognitive function; Elderly; Erectile function; Free testosterone; Prostatism

Indexed keywords

TESTOSTERONE;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; BLOOD SAMPLING; BONE DENSITY; CARDIOVASCULAR DISEASE; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; ELDERLY CARE; ERECTILE DYSFUNCTION; GERIATRIC ASSESSMENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; OBESITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PROSTATISM; TESTOSTERONE BLOOD LEVEL;

EID: 48449090342     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03324771     Document Type: Article

References (43)

1. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26: 833-76.
2. Lunenfeld B. Endocrinology of the aging male. Minerva Ginecol 2006; 58: 153-70.
3. Isidori AM, Giannetta E, Pozza C, Bonifacio V, Isidori A. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest 2005; 28 (Suppl): 73-9.
4. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61-5.
5. Lawton MP, Broody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
6. Folstein MF, Folstein JE, McHugh PR. "Mini Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
7. Stahelin HB, Monsch AU, Spiegel R. Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int Psychogeriatr 1997; 9 (Suppl 1): 123-30.
8. Hachinski VC, Iliff LD, Zilkha E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-7.
9. Diagnostic and Statistical Manual of Mental Disorders. Fourth Ed. Washington: American Psychiatric Association, 1994.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-44.
11. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
12. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale. A preliminary report. J Psychiatr Res 1983; 17: 37-49.
13. Mey C, Michel MC, McEwen J, Moreland T. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur Urol 1998; 33: 481-8.
14. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urology 2000; 56: 477-81.
15. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. Aging Male 2002; 5: 74-86.
16. Harman SM, Matter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86: 724-31.
17. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87: 589-98.
18. Simon D, Preziosi P, Barrett-Connor E, et al. The influence of aging on plasma sex hormones in men. The Telecom-study. Am J Epidemiol 1992; 135: 783-91.
19. Ferini RL, Barret-Connor E. Sex hormones and age: a cross sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiology 1998; 147: 750-4.
20. Vermeulen A, Kaufman JM, Goemaere S, Van Pottelberg I. Estradiol in elderly men. Aging Male 2003; 5: 98-102.
21. Khosla S, Melton LJ 3rd, Riggs BL. Estrogens and bone health in men. Calcif Tissue Int 2001; 69: 189-92.
22. Faustini-Fustini M, Rochira V, Carani C. Oestrogen deficiency in men: where are we today? Eur J Endocrinol 1999; 140: 111-29.
23. Christ-Crain M, Meier C, Huber P, Zimmerli L, Trummler M, Müller B. Comparison of different methods for the measurement of serum testosterone in the aging male. Swiss Med Wkly 2004; 134: 193-7.
24. Okamura K, Ando F, Shimokata H. Serum total and free testosterone level of Japanese men: a population-based study. Int J Urol 2005; 12: 810-4.
25. Gruschke A, Kuhl H. Validity of radioimmunological methods for determining free testosterone in serum. Fertil Steril 2001; 76: 576-82.
26. Tsitouras PD, Martin CE, Harman SM. Relationship of serum testosterone to sexual activity in healthy elderly men. J Gerontol 1982; 37: 288-93.
27. Perry PJ, Lund BC, Arndt S, et al. Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy. Ann Clin Psychiatry 2001; 13: 75-80.
28. T'Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004; 29: 201-14.
29. Marcelli M, Cunningham GR. Hormonal signaling in prostatic hyperplasia and neoplasia. J Clin Endocrinol Metab. 1999; 84: 3463-8.
30. Cankurtaran M, Yavuz BB, Halil M, Dagli N, Ariogul S. General characteristics, clinical features and related factors of osteoporosis in a group of elderly Turkish men. Aging Clin Exp Res 2005; 17: 108-15.
31. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85: 3276-82.
32. Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role of bioavailable estrogen. J Clin Endocrinol Metab 1998; 83: 2266-74.
33. Drinka PJ, Olson J, Bauwens S, Voeks SK, Carlson I, Wilson M. Lack of association between free testosterone and bone density separate from age in elderly males. Calcif Tissue Int 1993; 52: 67-9.
34. Van Pottelberg I, Goemaere S, Kaufman JM. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 2003; 88: 3075-81.
35. Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279-302.
36. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383-90.
37. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003; 24: 313-40.
38. Moffat SD. Effects of testosterone on cognitive and brain aging in elderly men. Ann NY Acad Sci 2005; 1055: 80-92.
39. Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci 2006; 10: 77-82.
40. Schweinger U, Deuschle M, Weber B, et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 1999; 61: 292-6.
41. Barrett-Connor E, von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999; 84: 573-7.
42. Kaneda Y, Fujii A. No relationship between testosterone levels and depressive symptoms in aging men. Eur Psychiatry 2002; 17: 411-3.
43. T'Sjoen GG, De Vos S, Goemaere S, et al. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 2005; 53: 636-2.